

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.57901407 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.57901407 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.06734341 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.06734341 |
| 5 | oligosaccharide catabolic process (GO:0009313) | 4.64263010 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.62862360 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.56869764 |
| 8 | central nervous system myelination (GO:0022010) | 4.52363498 |
| 9 | axon ensheathment in central nervous system (GO:0032291) | 4.52363498 |
| 10 | cell adhesion mediated by integrin (GO:0033627) | 4.41322519 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.40642479 |
| 12 | glycosphingolipid catabolic process (GO:0046479) | 4.38353649 |
| 13 | fatty acid elongation (GO:0030497) | 4.34880522 |
| 14 | protein localization to endosome (GO:0036010) | 4.16459072 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.16118307 |
| 16 | protein carboxylation (GO:0018214) | 4.16118307 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.00153373 |
| 18 | plasma lipoprotein particle clearance (GO:0034381) | 3.99334969 |
| 19 | glycolipid catabolic process (GO:0019377) | 3.89521216 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 3.84028032 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.61376702 |
| 22 | reverse cholesterol transport (GO:0043691) | 3.59929194 |
| 23 | complement activation, alternative pathway (GO:0006957) | 3.58622669 |
| 24 | urea cycle (GO:0000050) | 3.58266233 |
| 25 | urea metabolic process (GO:0019627) | 3.58266233 |
| 26 | regulation of cholesterol esterification (GO:0010872) | 3.56125672 |
| 27 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.55735161 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 3.53576486 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 3.52280658 |
| 30 | glyoxylate metabolic process (GO:0046487) | 3.51879936 |
| 31 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.51344582 |
| 32 | regulation of protein activation cascade (GO:2000257) | 3.49043268 |
| 33 | tyrosine metabolic process (GO:0006570) | 3.46859788 |
| 34 | regulation of cholesterol storage (GO:0010885) | 3.46843016 |
| 35 | kynurenine metabolic process (GO:0070189) | 3.46113114 |
| 36 | very long-chain fatty acid metabolic process (GO:0000038) | 3.45566982 |
| 37 | tryptophan catabolic process (GO:0006569) | 3.45008585 |
| 38 | indole-containing compound catabolic process (GO:0042436) | 3.45008585 |
| 39 | indolalkylamine catabolic process (GO:0046218) | 3.45008585 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 3.43166985 |
| 41 | macromolecular complex remodeling (GO:0034367) | 3.43166985 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 3.43166985 |
| 43 | * cholesterol efflux (GO:0033344) | 3.42881862 |
| 44 | ceramide catabolic process (GO:0046514) | 3.42121425 |
| 45 | hemidesmosome assembly (GO:0031581) | 3.41618787 |
| 46 | phospholipid efflux (GO:0033700) | 3.41237477 |
| 47 | skin morphogenesis (GO:0043589) | 3.41106422 |
| 48 | apoptotic cell clearance (GO:0043277) | 3.39425664 |
| 49 | cysteine metabolic process (GO:0006534) | 3.36144178 |
| 50 | phospholipid homeostasis (GO:0055091) | 3.36032823 |
| 51 | regulation of fibrinolysis (GO:0051917) | 3.34722888 |
| 52 | tryptophan metabolic process (GO:0006568) | 3.33265240 |
| 53 | nitrogen cycle metabolic process (GO:0071941) | 3.31657496 |
| 54 | * bile acid metabolic process (GO:0008206) | 3.31300300 |
| 55 | cellular response to arsenic-containing substance (GO:0071243) | 3.29350751 |
| 56 | positive regulation of extracellular matrix organization (GO:1903055) | 3.29234718 |
| 57 | iron ion import (GO:0097286) | 3.29045134 |
| 58 | regulation of complement activation (GO:0030449) | 3.27544874 |
| 59 | protein-lipid complex assembly (GO:0065005) | 3.24782140 |
| 60 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.24772655 |
| 61 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.22451728 |
| 62 | hyaluronan catabolic process (GO:0030214) | 3.21657123 |
| 63 | plasma lipoprotein particle assembly (GO:0034377) | 3.21223971 |
| 64 | regulation of early endosome to late endosome transport (GO:2000641) | 3.20307908 |
| 65 | negative regulation of lipase activity (GO:0060192) | 3.20040571 |
| 66 | low-density lipoprotein particle remodeling (GO:0034374) | 3.13975952 |
| 67 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.12069159 |
| 68 | heme transport (GO:0015886) | 3.12008204 |
| 69 | coenzyme catabolic process (GO:0009109) | 3.10255699 |
| 70 | cofactor catabolic process (GO:0051187) | 3.10135122 |
| 71 | pinocytosis (GO:0006907) | 3.08211434 |
| 72 | sulfur amino acid catabolic process (GO:0000098) | 3.07989828 |
| 73 | aromatic amino acid family metabolic process (GO:0009072) | 3.07193436 |
| 74 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.06911582 |
| 75 | response to thyroid hormone (GO:0097066) | 3.05353474 |
| 76 | response to methylmercury (GO:0051597) | 3.03726431 |
| 77 | fibrinolysis (GO:0042730) | 3.03216744 |
| 78 | acylglycerol homeostasis (GO:0055090) | 3.02802650 |
| 79 | triglyceride homeostasis (GO:0070328) | 3.02802650 |
| 80 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.02674151 |
| 81 | regulation of female gonad development (GO:2000194) | 3.01201747 |
| 82 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.99827010 |
| 83 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.98267797 |
| 84 | osteoclast differentiation (GO:0030316) | 2.98024812 |
| 85 | mannose metabolic process (GO:0006013) | 2.97291266 |
| 86 | negative regulation of sterol transport (GO:0032372) | 2.96137584 |
| 87 | negative regulation of cholesterol transport (GO:0032375) | 2.96137584 |
| 88 | protein-lipid complex subunit organization (GO:0071825) | 2.94359145 |
| 89 | amino-acid betaine metabolic process (GO:0006577) | 2.92657166 |
| 90 | regulation of cholesterol metabolic process (GO:0090181) | 2.92372825 |
| 91 | glutamate metabolic process (GO:0006536) | 2.90574658 |
| 92 | * cholesterol homeostasis (GO:0042632) | 2.90507691 |
| 93 | plasma lipoprotein particle organization (GO:0071827) | 2.90297879 |
| 94 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.85729289 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.85729289 |
| 96 | * sterol homeostasis (GO:0055092) | 2.84779571 |
| 97 | ethanol oxidation (GO:0006069) | 2.84431817 |
| 98 | positive regulation of lipid catabolic process (GO:0050996) | 2.82048430 |
| 99 | sphingosine metabolic process (GO:0006670) | 2.81804261 |
| 100 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.81329638 |
| 101 | alpha-amino acid catabolic process (GO:1901606) | 2.80946447 |
| 102 | adhesion of symbiont to host (GO:0044406) | 2.78518476 |
| 103 | regulation of macrophage chemotaxis (GO:0010758) | 2.77167705 |
| 104 | regulation of lipoprotein metabolic process (GO:0050746) | 2.77084901 |
| 105 | positive regulation by symbiont of host defense response (GO:0052509) | 2.76761533 |
| 106 | modulation by symbiont of host defense response (GO:0052031) | 2.76761533 |
| 107 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.76761533 |
| 108 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.76761533 |
| 109 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.76761533 |
| 110 | modulation by symbiont of host immune response (GO:0052553) | 2.76761533 |
| 111 | lipoprotein metabolic process (GO:0042157) | 2.76544128 |
| 112 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.75895351 |
| 113 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.75690657 |
| 114 | cellular glucuronidation (GO:0052695) | 2.75023148 |
| 115 | low-density lipoprotein particle clearance (GO:0034383) | 2.74712663 |
| 116 | endodermal cell differentiation (GO:0035987) | 2.74652565 |
| 117 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.74049064 |
| 118 | opsonization (GO:0008228) | 2.74006111 |
| 119 | homocysteine metabolic process (GO:0050667) | 2.73295942 |
| 120 | ensheathment of neurons (GO:0007272) | 2.72882709 |
| 121 | axon ensheathment (GO:0008366) | 2.72882709 |
| 122 | linoleic acid metabolic process (GO:0043651) | 2.72491246 |
| 123 | amyloid precursor protein catabolic process (GO:0042987) | 2.72252639 |
| 124 | myelination (GO:0042552) | 2.70985858 |
| 125 | cholesterol biosynthetic process (GO:0006695) | 2.70974485 |
| 126 | cell-substrate junction assembly (GO:0007044) | 2.70252268 |
| 127 | decidualization (GO:0046697) | 2.69913853 |
| 128 | bile acid and bile salt transport (GO:0015721) | 2.69531685 |
| 129 | import into cell (GO:0098657) | 2.69028206 |
| 130 | regulation of cholesterol homeostasis (GO:2000188) | 2.68239248 |
| 131 | regulation of mononuclear cell migration (GO:0071675) | 2.67769625 |
| 132 | regulation of bile acid biosynthetic process (GO:0070857) | 2.67640628 |
| 133 | barbed-end actin filament capping (GO:0051016) | 2.67531392 |
| 134 | cellular modified amino acid catabolic process (GO:0042219) | 2.67511352 |
| 135 | short-chain fatty acid metabolic process (GO:0046459) | 2.66455186 |
| 136 | membrane lipid catabolic process (GO:0046466) | 2.65807644 |
| 137 | keratan sulfate catabolic process (GO:0042340) | 2.64070575 |
| 138 | sphingolipid catabolic process (GO:0030149) | 2.61030462 |
| 139 | response to laminar fluid shear stress (GO:0034616) | 2.60959425 |
| 140 | hypotonic response (GO:0006971) | 2.60308247 |
| 141 | macroautophagy (GO:0016236) | 2.58976278 |
| 142 | response to magnesium ion (GO:0032026) | 2.58575995 |
| 143 | amino sugar catabolic process (GO:0046348) | 2.54409667 |
| 144 | substrate-dependent cell migration (GO:0006929) | 2.51451824 |
| 145 | membrane protein ectodomain proteolysis (GO:0006509) | 2.48713576 |
| 146 | negative regulation of lipid storage (GO:0010888) | 2.45624793 |
| 147 | COPI coating of Golgi vesicle (GO:0048205) | 2.45536877 |
| 148 | Golgi transport vesicle coating (GO:0048200) | 2.45536877 |
| 149 | positive regulation of p38MAPK cascade (GO:1900745) | 2.42793576 |
| 150 | protein hydroxylation (GO:0018126) | 2.42486850 |
| 151 | cortical actin cytoskeleton organization (GO:0030866) | 2.41647755 |
| 152 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.41141015 |
| 153 | regulation of vitamin metabolic process (GO:0030656) | 2.40544102 |
| 154 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.38809163 |
| 155 | protein kinase C signaling (GO:0070528) | 2.36982295 |
| 156 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.36606734 |
| 157 | cellular response to ethanol (GO:0071361) | 2.36174925 |
| 158 | regulation of apoptotic cell clearance (GO:2000425) | 2.35241038 |
| 159 | mesodermal cell differentiation (GO:0048333) | 2.34899126 |
| 160 | basement membrane organization (GO:0071711) | 2.33939440 |
| 161 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.32477458 |
| 162 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.31409512 |
| 163 | sphingoid metabolic process (GO:0046519) | 2.30310480 |
| 164 | detection of molecule of bacterial origin (GO:0032490) | 2.28673451 |
| 165 | cellular copper ion homeostasis (GO:0006878) | 2.28158344 |
| 166 | epithelial cell-cell adhesion (GO:0090136) | 2.27353663 |
| 167 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.26873589 |
| 168 | response to peptidoglycan (GO:0032494) | 2.25862207 |
| 169 | surfactant homeostasis (GO:0043129) | 2.25294884 |
| 170 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.25094682 |
| 171 | peptide catabolic process (GO:0043171) | 2.24582734 |
| 172 | diol metabolic process (GO:0034311) | 2.24508222 |
| 173 | hyaluronan metabolic process (GO:0030212) | 2.24492842 |
| 174 | regulation of extracellular matrix organization (GO:1903053) | 2.23660930 |
| 175 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.23594020 |
| 176 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.23578772 |
| 177 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.23371497 |
| 178 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.21739572 |
| 179 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.21252881 |
| 180 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.20477878 |
| 181 | positive regulation of steroid metabolic process (GO:0045940) | 2.19868085 |
| 182 | mammary gland epithelial cell proliferation (GO:0033598) | 2.19712712 |
| 183 | embryo implantation (GO:0007566) | 2.18916263 |
| 184 | cortical cytoskeleton organization (GO:0030865) | 2.18798033 |
| 185 | myeloid dendritic cell differentiation (GO:0043011) | 2.18358933 |
| 186 | regulation of acrosome reaction (GO:0060046) | 2.15967694 |
| 187 | receptor catabolic process (GO:0032801) | 2.15876251 |
| 188 | positive regulation of leukocyte degranulation (GO:0043302) | 2.15034682 |
| 189 | virion attachment to host cell (GO:0019062) | 2.14512144 |
| 190 | adhesion of symbiont to host cell (GO:0044650) | 2.14512144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.21586337 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.20685972 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.62717027 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.08469821 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.83450721 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.59018686 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.52745047 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.21346215 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.62012084 |
| 10 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.61865349 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38648189 |
| 12 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.28192468 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15493016 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.13645264 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.07381347 |
| 16 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.06318407 |
| 17 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.06318407 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05107985 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.97689032 |
| 20 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.95084958 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87085705 |
| 22 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.78656256 |
| 23 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.76921662 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76839817 |
| 25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.73537143 |
| 26 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.73159570 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72711829 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68736249 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.66856669 |
| 30 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66499642 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66489301 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65483492 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.59682440 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.54215890 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53751840 |
| 36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53622418 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51458287 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51047640 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.51037033 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48805587 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.48198361 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.46013802 |
| 43 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.46013802 |
| 44 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.45356110 |
| 45 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.44995666 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44880886 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41566504 |
| 48 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38148513 |
| 49 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.34878321 |
| 50 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.30638162 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30537080 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30530986 |
| 53 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.28938220 |
| 54 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28081596 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25651025 |
| 56 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.25345731 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22902706 |
| 58 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22551393 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22461124 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22120379 |
| 61 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21754824 |
| 62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21529717 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20717580 |
| 64 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.20539314 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18299386 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.18244777 |
| 67 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.17437963 |
| 68 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17348089 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16814099 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16565009 |
| 71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08532620 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08189527 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07867168 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07536663 |
| 75 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.06770416 |
| 76 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06247617 |
| 77 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.05185806 |
| 78 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04320258 |
| 79 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03406339 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02389965 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02275688 |
| 82 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01710540 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01469361 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99995326 |
| 85 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98791152 |
| 86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98749280 |
| 87 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98614147 |
| 88 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98492591 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98270108 |
| 90 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.98131173 |
| 91 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97761996 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97710081 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97611143 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97239359 |
| 95 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.96858381 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96575034 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96004612 |
| 98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95965326 |
| 99 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.95578000 |
| 100 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95044770 |
| 101 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94568562 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93669427 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93431080 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93241173 |
| 105 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93181755 |
| 106 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92195305 |
| 107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91185354 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90424077 |
| 109 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88345783 |
| 110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87949542 |
| 111 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86668618 |
| 112 | * CLOCK_20551151_ChIP-Seq_293T_Human | 0.86562782 |
| 113 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86338957 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86022305 |
| 115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85186936 |
| 116 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84602984 |
| 117 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.83949056 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83686499 |
| 119 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83582355 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82564911 |
| 121 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.81365256 |
| 122 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79238746 |
| 123 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78704850 |
| 124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78051859 |
| 125 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77716315 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77462191 |
| 127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76624902 |
| 128 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.76445079 |
| 129 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.74535756 |
| 130 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.74390044 |
| 131 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.74095413 |
| 132 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.74095413 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73540589 |
| 134 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.73123877 |
| 135 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.71927292 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.71511895 |
| 137 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70040463 |
| 138 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.69757856 |
| 139 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.69583344 |
| 140 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68317071 |
| 141 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.67720790 |
| 142 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.67423165 |
| 143 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.67109960 |
| 144 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64707606 |
| 145 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.64308675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.68307050 |
| 2 | MP0005360_urolithiasis | 5.03476325 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.24179824 |
| 4 | MP0005365_abnormal_bile_salt | 4.07389612 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.85232605 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.44223604 |
| 7 | * MP0009840_abnormal_foam_cell | 3.30488885 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.94428477 |
| 9 | * MP0003690_abnormal_glial_cell | 2.92312434 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.89103305 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.84997576 |
| 12 | * MP0000920_abnormal_myelination | 2.84484933 |
| 13 | MP0003252_abnormal_bile_duct | 2.82471341 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.74416451 |
| 15 | MP0005083_abnormal_biliary_tract | 2.66180596 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.46188776 |
| 17 | MP0003195_calcinosis | 2.42111642 |
| 18 | MP0000604_amyloidosis | 2.36334269 |
| 19 | MP0006054_spinal_hemorrhage | 2.25504908 |
| 20 | MP0003091_abnormal_cell_migration | 2.23875585 |
| 21 | MP0005023_abnormal_wound_healing | 2.12600873 |
| 22 | MP0006082_CNS_inflammation | 2.01460931 |
| 23 | * MP0002118_abnormal_lipid_homeostasis | 1.98965618 |
| 24 | MP0005332_abnormal_amino_acid | 1.96212796 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.93775111 |
| 26 | MP0005451_abnormal_body_composition | 1.91572584 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.86684644 |
| 28 | MP0004233_abnormal_muscle_weight | 1.86073174 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.76533270 |
| 30 | MP0004272_abnormal_basement_membrane | 1.74541881 |
| 31 | MP0003329_amyloid_beta_deposits | 1.72008121 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.70562273 |
| 33 | MP0003011_delayed_dark_adaptation | 1.64941941 |
| 34 | MP0002254_reproductive_system_inflammat | 1.63471543 |
| 35 | * MP0000609_abnormal_liver_physiology | 1.61942866 |
| 36 | MP0000371_diluted_coat_color | 1.56684530 |
| 37 | MP0000343_altered_response_to | 1.52255138 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.51962882 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41959586 |
| 40 | MP0003075_altered_response_to | 1.38786738 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.36122567 |
| 42 | MP0004381_abnormal_hair_follicle | 1.35621564 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.31147505 |
| 44 | MP0000858_altered_metastatic_potential | 1.30168902 |
| 45 | MP0001915_intracranial_hemorrhage | 1.29555832 |
| 46 | MP0003448_altered_tumor_morphology | 1.28143382 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.27990553 |
| 48 | * MP0003634_abnormal_glial_cell | 1.27186768 |
| 49 | MP0002090_abnormal_vision | 1.26952986 |
| 50 | MP0002089_abnormal_postnatal_growth/wei | 1.22831471 |
| 51 | MP0002896_abnormal_bone_mineralization | 1.22411096 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.19548497 |
| 53 | * MP0002419_abnormal_innate_immunity | 1.13370956 |
| 54 | MP0004130_abnormal_muscle_cell | 1.13005744 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.11403191 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.10970666 |
| 57 | MP0005408_hypopigmentation | 1.09957520 |
| 58 | MP0003941_abnormal_skin_development | 1.09936946 |
| 59 | MP0010678_abnormal_skin_adnexa | 1.09383627 |
| 60 | MP0001849_ear_inflammation | 1.07359393 |
| 61 | MP0009785_altered_susceptibility_to | 1.07252404 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.07153143 |
| 63 | MP0005409_darkened_coat_color | 1.06607160 |
| 64 | MP0003303_peritoneal_inflammation | 1.06589909 |
| 65 | MP0009764_decreased_sensitivity_to | 1.06188368 |
| 66 | MP0000383_abnormal_hair_follicle | 1.03846932 |
| 67 | MP0005310_abnormal_salivary_gland | 1.03021441 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.02361201 |
| 69 | MP0009763_increased_sensitivity_to | 1.01352672 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 1.00403638 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 0.97365694 |
| 72 | MP0001851_eye_inflammation | 0.95982091 |
| 73 | MP0003632_abnormal_nervous_system | 0.95913184 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 0.94297107 |
| 75 | MP0005197_abnormal_uvea_morphology | 0.94292978 |
| 76 | MP0001216_abnormal_epidermal_layer | 0.93875913 |
| 77 | MP0003436_decreased_susceptibility_to | 0.93794746 |
| 78 | MP0003868_abnormal_feces_composition | 0.93547557 |
| 79 | MP0008469_abnormal_protein_level | 0.93370762 |
| 80 | MP0000579_abnormal_nail_morphology | 0.92836514 |
| 81 | MP0000733_abnormal_muscle_development | 0.92656933 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 0.92175941 |
| 83 | MP0003633_abnormal_nervous_system | 0.90139657 |
| 84 | MP0004885_abnormal_endolymph | 0.89666918 |
| 85 | MP0005621_abnormal_cell_physiology | 0.89626446 |
| 86 | MP0000015_abnormal_ear_pigmentation | 0.89378647 |
| 87 | MP0005670_abnormal_white_adipose | 0.88724884 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.87285030 |
| 89 | MP0002060_abnormal_skin_morphology | 0.86673664 |
| 90 | MP0002971_abnormal_brown_adipose | 0.86346908 |
| 91 | MP0000647_abnormal_sebaceous_gland | 0.85757661 |
| 92 | MP0005000_abnormal_immune_tolerance | 0.85560360 |
| 93 | MP0002295_abnormal_pulmonary_circulatio | 0.85254750 |
| 94 | MP0005166_decreased_susceptibility_to | 0.84228935 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.83790268 |
| 96 | MP0009384_cardiac_valve_regurgitation | 0.81717525 |
| 97 | MP0003828_pulmonary_edema | 0.81047317 |
| 98 | MP0003724_increased_susceptibility_to | 0.78756249 |
| 99 | MP0003705_abnormal_hypodermis_morpholog | 0.78524024 |
| 100 | MP0003879_abnormal_hair_cell | 0.77558284 |
| 101 | MP0010307_abnormal_tumor_latency | 0.77537899 |
| 102 | MP0003795_abnormal_bone_structure | 0.77434129 |
| 103 | MP0009643_abnormal_urine_homeostasis | 0.77366800 |
| 104 | MP0008260_abnormal_autophagy | 0.77269592 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.77123494 |
| 106 | MP0001533_abnormal_skeleton_physiology | 0.76224970 |
| 107 | MP0003631_nervous_system_phenotype | 0.76211009 |
| 108 | MP0000685_abnormal_immune_system | 0.76199369 |
| 109 | MP0003186_abnormal_redox_activity | 0.74914053 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.74537697 |
| 111 | MP0003045_fibrosis | 0.74348358 |
| 112 | MP0004858_abnormal_nervous_system | 0.73701576 |
| 113 | MP0005595_abnormal_vascular_smooth | 0.73638953 |
| 114 | MP0001853_heart_inflammation | 0.73186201 |
| 115 | * MP0002229_neurodegeneration | 0.72863409 |
| 116 | MP0009697_abnormal_copulation | 0.72724017 |
| 117 | * MP0002452_abnormal_antigen_presenting | 0.71712993 |
| 118 | * MP0000598_abnormal_liver_morphology | 0.71330359 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.70799993 |
| 120 | * MP0003950_abnormal_plasma_membrane | 0.70377713 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.70376243 |
| 122 | MP0005171_absent_coat_pigmentation | 0.70073690 |
| 123 | MP0005164_abnormal_response_to | 0.70070199 |
| 124 | MP0002998_abnormal_bone_remodeling | 0.69715106 |
| 125 | MP0002075_abnormal_coat/hair_pigmentati | 0.69713986 |
| 126 | MP0000639_abnormal_adrenal_gland | 0.69067544 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.68801006 |
| 128 | MP0001764_abnormal_homeostasis | 0.68620687 |
| 129 | MP0002405_respiratory_system_inflammati | 0.68028684 |
| 130 | MP0000767_abnormal_smooth_muscle | 0.67697131 |
| 131 | MP0001958_emphysema | 0.67513622 |
| 132 | MP0003718_maternal_effect | 0.66867719 |
| 133 | MP0001661_extended_life_span | 0.66705016 |
| 134 | MP0005395_other_phenotype | 0.65265423 |
| 135 | MP0004510_myositis | 0.65132445 |
| 136 | MP0003279_aneurysm | 0.64899787 |
| 137 | MP0005390_skeleton_phenotype | 0.64638638 |
| 138 | MP0005387_immune_system_phenotype | 0.64447074 |
| 139 | MP0001790_abnormal_immune_system | 0.64447074 |
| 140 | MP0004947_skin_inflammation | 0.63553492 |
| 141 | MP0000747_muscle_weakness | 0.62777126 |
| 142 | MP0005025_abnormal_response_to | 0.60038968 |
| 143 | MP0001324_abnormal_eye_pigmentation | 0.57999605 |
| 144 | MP0000569_abnormal_digit_pigmentation | 0.57887506 |
| 145 | MP0009642_abnormal_blood_homeostasis | 0.57851532 |
| 146 | MP0000465_gastrointestinal_hemorrhage | 0.56863009 |
| 147 | * MP0005334_abnormal_fat_pad | 0.55063784 |
| 148 | MP0001177_atelectasis | 0.54838995 |
| 149 | MP0002933_joint_inflammation | 0.54764845 |
| 150 | MP0003136_yellow_coat_color | 0.53042161 |
| 151 | MP0000249_abnormal_blood_vessel | 0.52319053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.59010748 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.58544937 |
| 3 | Xanthomatosis (HP:0000991) | 5.33118464 |
| 4 | Hyperlipoproteinemia (HP:0010980) | 5.11089387 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.05982874 |
| 6 | Complement deficiency (HP:0004431) | 4.62823303 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.21337727 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.11199045 |
| 9 | Axonal loss (HP:0003447) | 4.00893941 |
| 10 | Epidermoid cyst (HP:0200040) | 3.87988842 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.80845245 |
| 12 | Joint hemorrhage (HP:0005261) | 3.79781856 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 3.62148221 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 3.56139487 |
| 15 | Vertebral compression fractures (HP:0002953) | 3.53062784 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.52424275 |
| 17 | Myocardial infarction (HP:0001658) | 3.49103297 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.47565727 |
| 19 | Hypercholesterolemia (HP:0003124) | 3.39746535 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.35018194 |
| 21 | Abnormality of complement system (HP:0005339) | 3.30551574 |
| 22 | * Neurofibrillary tangles (HP:0002185) | 3.28915641 |
| 23 | Fat malabsorption (HP:0002630) | 3.12486791 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.07565774 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.07181107 |
| 26 | Apathy (HP:0000741) | 3.07066864 |
| 27 | Glomerulonephritis (HP:0000099) | 3.04948966 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.01144761 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.99189834 |
| 30 | Amyloidosis (HP:0011034) | 2.96988483 |
| 31 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.90885355 |
| 32 | Diminished motivation (HP:0000745) | 2.87409022 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.86738621 |
| 34 | Hyperammonemia (HP:0001987) | 2.82019751 |
| 35 | Peripheral demyelination (HP:0011096) | 2.78983755 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.77842216 |
| 37 | Nuclear cataract (HP:0100018) | 2.77777974 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.71364887 |
| 39 | Cervical subluxation (HP:0003308) | 2.70329327 |
| 40 | Steatorrhea (HP:0002570) | 2.66787022 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.64202960 |
| 42 | Vascular calcification (HP:0004934) | 2.62975126 |
| 43 | * Loss of speech (HP:0002371) | 2.60417595 |
| 44 | Skin nodule (HP:0200036) | 2.60377919 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.57296706 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.57296706 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.57296706 |
| 48 | Dysostosis multiplex (HP:0000943) | 2.57197402 |
| 49 | Protrusio acetabuli (HP:0003179) | 2.57120083 |
| 50 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.56994936 |
| 51 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.56994936 |
| 52 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.56501542 |
| 53 | Osteolytic defects of the hand bones (HP:0009699) | 2.56501542 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.53434714 |
| 55 | Ketosis (HP:0001946) | 2.49287414 |
| 56 | Spondylolisthesis (HP:0003302) | 2.47415692 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.46822159 |
| 58 | Turricephaly (HP:0000262) | 2.46055750 |
| 59 | Abnormality of glycine metabolism (HP:0010895) | 2.44903981 |
| 60 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.44903981 |
| 61 | Gingival bleeding (HP:0000225) | 2.42822827 |
| 62 | Hepatosplenomegaly (HP:0001433) | 2.42716094 |
| 63 | Flat acetabular roof (HP:0003180) | 2.36307350 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.34349051 |
| 65 | Metaphyseal irregularity (HP:0003025) | 2.30277321 |
| 66 | Disinhibition (HP:0000734) | 2.27551728 |
| 67 | Tetraparesis (HP:0002273) | 2.27011687 |
| 68 | Onion bulb formation (HP:0003383) | 2.26016888 |
| 69 | Paraparesis (HP:0002385) | 2.24595771 |
| 70 | Slow saccadic eye movements (HP:0000514) | 2.21695725 |
| 71 | Autoimmune thrombocytopenia (HP:0001973) | 2.20736106 |
| 72 | Retinal atrophy (HP:0001105) | 2.20713454 |
| 73 | Hyperglycinemia (HP:0002154) | 2.19550889 |
| 74 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.18362577 |
| 75 | * Cerebral inclusion bodies (HP:0100314) | 2.17525245 |
| 76 | Subacute progressive viral hepatitis (HP:0006572) | 2.15763605 |
| 77 | Esophageal varix (HP:0002040) | 2.14600178 |
| 78 | Interstitial pulmonary disease (HP:0006530) | 2.14123391 |
| 79 | Mitral stenosis (HP:0001718) | 2.13211894 |
| 80 | Hypophosphatemic rickets (HP:0004912) | 2.10423584 |
| 81 | Ovoid vertebral bodies (HP:0003300) | 2.08305939 |
| 82 | Upper limb amyotrophy (HP:0009129) | 2.07361367 |
| 83 | Distal upper limb amyotrophy (HP:0007149) | 2.07361367 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.06956136 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06956136 |
| 86 | Spastic tetraparesis (HP:0001285) | 2.05648426 |
| 87 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05540655 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05540655 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05540655 |
| 90 | Protuberant abdomen (HP:0001538) | 2.05473637 |
| 91 | Recurrent bacterial skin infections (HP:0005406) | 2.04348938 |
| 92 | Parakeratosis (HP:0001036) | 2.03017781 |
| 93 | Clumsiness (HP:0002312) | 2.02446104 |
| 94 | Hypoglycemic coma (HP:0001325) | 2.01568900 |
| 95 | Bone pain (HP:0002653) | 2.01547492 |
| 96 | Abnormality of the corticospinal tract (HP:0002492) | 2.01057845 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 2.00595743 |
| 98 | Natal tooth (HP:0000695) | 2.00402903 |
| 99 | Abnormality of carpal bone ossification (HP:0006257) | 1.98467920 |
| 100 | Hyperglycinuria (HP:0003108) | 1.97916906 |
| 101 | Nephritis (HP:0000123) | 1.96859793 |
| 102 | * Abnormality of macrophages (HP:0004311) | 1.96465058 |
| 103 | Intention tremor (HP:0002080) | 1.95452405 |
| 104 | Abnormality of the intrinsic pathway (HP:0010989) | 1.95130303 |
| 105 | Premature rupture of membranes (HP:0001788) | 1.93623553 |
| 106 | Malnutrition (HP:0004395) | 1.90813464 |
| 107 | Abnormal gallbladder physiology (HP:0012438) | 1.90615010 |
| 108 | Cholecystitis (HP:0001082) | 1.90615010 |
| 109 | Sensorimotor neuropathy (HP:0007141) | 1.89928997 |
| 110 | Wormian bones (HP:0002645) | 1.89043855 |
| 111 | Cerebral aneurysm (HP:0004944) | 1.88932411 |
| 112 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.87781297 |
| 113 | Hepatocellular carcinoma (HP:0001402) | 1.86702285 |
| 114 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.86223230 |
| 115 | Flared iliac wings (HP:0002869) | 1.86138922 |
| 116 | Arterial tortuosity (HP:0005116) | 1.84239176 |
| 117 | Spastic paraparesis (HP:0002313) | 1.83520571 |
| 118 | Cholelithiasis (HP:0001081) | 1.83272003 |
| 119 | Delayed CNS myelination (HP:0002188) | 1.82139392 |
| 120 | Atrophic scars (HP:0001075) | 1.81005844 |
| 121 | Dysmetric saccades (HP:0000641) | 1.80992750 |
| 122 | Coarse hair (HP:0002208) | 1.79516093 |
| 123 | Abnormal ossification of hand bones (HP:0005921) | 1.79155603 |
| 124 | J-shaped sella turcica (HP:0002680) | 1.78165817 |
| 125 | Hemorrhage of the eye (HP:0011885) | 1.77668940 |
| 126 | Vascular tortuosity (HP:0004948) | 1.77050176 |
| 127 | Asymmetric septal hypertrophy (HP:0001670) | 1.76856730 |
| 128 | Milia (HP:0001056) | 1.76422411 |
| 129 | Upper motor neuron abnormality (HP:0002127) | 1.75564399 |
| 130 | Increased CSF protein (HP:0002922) | 1.74829842 |
| 131 | Recurrent skin infections (HP:0001581) | 1.74116832 |
| 132 | * Neuronal loss in central nervous system (HP:0002529) | 1.73739682 |
| 133 | Femoral bowing (HP:0002980) | 1.72240477 |
| 134 | Premature skin wrinkling (HP:0100678) | 1.72046079 |
| 135 | Ulnar bowing (HP:0003031) | 1.71074273 |
| 136 | Thin bony cortex (HP:0002753) | 1.70213754 |
| 137 | Hyporeflexia of lower limbs (HP:0002600) | 1.69042474 |
| 138 | Thick nail (HP:0001805) | 1.69012184 |
| 139 | Abnormality of the thoracic spine (HP:0100711) | 1.68623147 |
| 140 | Abnormality of proline metabolism (HP:0010907) | 1.68452350 |
| 141 | Hydroxyprolinuria (HP:0003080) | 1.68452350 |
| 142 | Pulmonary embolism (HP:0002204) | 1.67712039 |
| 143 | Sensory axonal neuropathy (HP:0003390) | 1.67215498 |
| 144 | Short nail (HP:0001799) | 1.66706068 |
| 145 | Recurrent abscess formation (HP:0002722) | 1.66187580 |
| 146 | Global brain atrophy (HP:0002283) | 1.66087060 |
| 147 | Heterotopia (HP:0002282) | 1.66001844 |
| 148 | Absent frontal sinuses (HP:0002688) | 1.65504647 |
| 149 | Abnormality of the acetabulum (HP:0003170) | 1.65235948 |
| 150 | Albinism (HP:0001022) | 1.63650394 |
| 151 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.63370450 |
| 152 | Hand muscle atrophy (HP:0009130) | 1.62486931 |
| 153 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.62049445 |
| 154 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.61941914 |
| 155 | Progressive neurologic deterioration (HP:0002344) | 1.61695002 |
| 156 | Tibial bowing (HP:0002982) | 1.59526449 |
| 157 | Elbow flexion contracture (HP:0002987) | 1.58840619 |
| 158 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.58592799 |
| 159 | Cupped ribs (HP:0000887) | 1.58262906 |
| 160 | Ankle contracture (HP:0006466) | 1.57390403 |
| 161 | Mutism (HP:0002300) | 1.56497572 |
| 162 | Cardiomegaly (HP:0001640) | 1.54989900 |
| 163 | * Dementia (HP:0000726) | 1.54818293 |
| 164 | Hyperacusis (HP:0010780) | 1.53984228 |
| 165 | Ankyloglossia (HP:0010296) | 1.53957857 |
| 166 | Alopecia of scalp (HP:0002293) | 1.53106483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB1 | 3.99559024 |
| 2 | CDK12 | 3.26934009 |
| 3 | STK39 | 2.94856479 |
| 4 | FGFR2 | 2.59616300 |
| 5 | PBK | 2.35454920 |
| 6 | DDR2 | 2.31697870 |
| 7 | SIK1 | 2.31268740 |
| 8 | PDGFRA | 2.25608623 |
| 9 | PKN1 | 2.15905073 |
| 10 | CAMK1G | 2.07405338 |
| 11 | MET | 2.04499226 |
| 12 | CAMK1D | 2.03790747 |
| 13 | TAOK3 | 2.00868374 |
| 14 | MAP3K9 | 1.94604483 |
| 15 | MAP3K3 | 1.92912685 |
| 16 | FGFR4 | 1.87935914 |
| 17 | OXSR1 | 1.81888369 |
| 18 | LATS2 | 1.74661109 |
| 19 | AKT3 | 1.68159262 |
| 20 | PTK2 | 1.64778125 |
| 21 | EPHA2 | 1.62814330 |
| 22 | ERBB4 | 1.52430519 |
| 23 | TGFBR2 | 1.52295706 |
| 24 | ERN1 | 1.51051113 |
| 25 | TYK2 | 1.50773318 |
| 26 | CDC42BPA | 1.49100975 |
| 27 | BCKDK | 1.47748581 |
| 28 | ARAF | 1.44266143 |
| 29 | MAPKAPK5 | 1.40227205 |
| 30 | TAOK2 | 1.40032981 |
| 31 | PRPF4B | 1.27795410 |
| 32 | JAK1 | 1.26944689 |
| 33 | ICK | 1.24888597 |
| 34 | INSRR | 1.22450846 |
| 35 | CSF1R | 1.22292512 |
| 36 | SGK223 | 1.21822964 |
| 37 | SGK494 | 1.21822964 |
| 38 | PAK4 | 1.19440410 |
| 39 | BLK | 1.18467823 |
| 40 | MAP3K13 | 1.17570744 |
| 41 | KIT | 1.17005809 |
| 42 | EPHA3 | 1.16733352 |
| 43 | PTK6 | 1.15937728 |
| 44 | FGR | 1.15370042 |
| 45 | CSNK1A1L | 1.10430364 |
| 46 | MAP3K14 | 1.10193431 |
| 47 | MTOR | 1.08971559 |
| 48 | TBK1 | 1.08780914 |
| 49 | CLK1 | 1.07849756 |
| 50 | EEF2K | 1.07097518 |
| 51 | MELK | 1.04973354 |
| 52 | STK38 | 1.04446683 |
| 53 | LATS1 | 1.03350068 |
| 54 | WNK1 | 1.03261711 |
| 55 | CSK | 1.01775100 |
| 56 | BMX | 0.99044625 |
| 57 | LMTK2 | 0.98353664 |
| 58 | MST1R | 0.98078880 |
| 59 | PRKD1 | 0.97896452 |
| 60 | MATK | 0.97738412 |
| 61 | PRKCQ | 0.93842928 |
| 62 | ZAP70 | 0.90210897 |
| 63 | TTN | 0.89738592 |
| 64 | ITK | 0.89229547 |
| 65 | PHKG1 | 0.89054703 |
| 66 | PHKG2 | 0.89054703 |
| 67 | GSK3A | 0.88617373 |
| 68 | CSNK1G1 | 0.88616875 |
| 69 | NEK9 | 0.88002887 |
| 70 | MAP3K1 | 0.87994118 |
| 71 | PIM2 | 0.87883808 |
| 72 | ACVR1B | 0.87878269 |
| 73 | ERBB2 | 0.87703853 |
| 74 | MAPK7 | 0.87574361 |
| 75 | MAPK11 | 0.87400250 |
| 76 | PDPK1 | 0.86912004 |
| 77 | MAP3K2 | 0.86819568 |
| 78 | JAK2 | 0.85984894 |
| 79 | IRAK3 | 0.84467137 |
| 80 | TRIB3 | 0.83774115 |
| 81 | NTRK1 | 0.83220549 |
| 82 | MAPK12 | 0.82549546 |
| 83 | PRKAA2 | 0.81747274 |
| 84 | BCR | 0.81735020 |
| 85 | MAPK15 | 0.80677770 |
| 86 | TRPM7 | 0.80677488 |
| 87 | NME2 | 0.79805092 |
| 88 | PAK2 | 0.79230223 |
| 89 | PIK3CG | 0.78665535 |
| 90 | ROCK2 | 0.78546150 |
| 91 | KSR1 | 0.78493409 |
| 92 | CSNK1G3 | 0.78106312 |
| 93 | MOS | 0.77394686 |
| 94 | FGFR3 | 0.76554199 |
| 95 | EPHA4 | 0.76427300 |
| 96 | PRKCH | 0.75135618 |
| 97 | PDK2 | 0.74382879 |
| 98 | HCK | 0.74183190 |
| 99 | PAK6 | 0.73446646 |
| 100 | CHUK | 0.71752493 |
| 101 | MARK3 | 0.70865762 |
| 102 | IRAK2 | 0.70743971 |
| 103 | PDGFRB | 0.69869943 |
| 104 | FES | 0.69726594 |
| 105 | NEK6 | 0.69435468 |
| 106 | CAMK2G | 0.68880969 |
| 107 | CSNK1G2 | 0.68542464 |
| 108 | CAMK2D | 0.66128401 |
| 109 | SGK3 | 0.65613090 |
| 110 | ABL2 | 0.63617236 |
| 111 | RAF1 | 0.61816988 |
| 112 | ABL1 | 0.61176703 |
| 113 | DMPK | 0.60906997 |
| 114 | MARK2 | 0.60585898 |
| 115 | EGFR | 0.60566144 |
| 116 | BRD4 | 0.60341850 |
| 117 | CDK6 | 0.60010183 |
| 118 | TYRO3 | 0.59935708 |
| 119 | FYN | 0.59772025 |
| 120 | MAP3K7 | 0.59741430 |
| 121 | MAP3K6 | 0.59614507 |
| 122 | IRAK1 | 0.58400459 |
| 123 | MAP3K8 | 0.57697522 |
| 124 | MAP2K3 | 0.56141940 |
| 125 | GRK7 | 0.55792620 |
| 126 | IKBKE | 0.55621867 |
| 127 | PAK3 | 0.53705979 |
| 128 | KSR2 | 0.53631354 |
| 129 | BMPR2 | 0.53012139 |
| 130 | PRKD2 | 0.52260130 |
| 131 | LIMK1 | 0.49998087 |
| 132 | CAMK2B | 0.49539153 |
| 133 | BRAF | 0.49467142 |
| 134 | STK24 | 0.48665274 |
| 135 | NUAK1 | 0.48572527 |
| 136 | PDK1 | 0.48302744 |
| 137 | RIPK1 | 0.48088211 |
| 138 | MAP3K5 | 0.47313992 |
| 139 | STK10 | 0.47114094 |
| 140 | SCYL2 | 0.45133401 |
| 141 | LCK | 0.44481457 |
| 142 | PRKCE | 0.44057656 |
| 143 | TAOK1 | 0.43917323 |
| 144 | IKBKB | 0.41845234 |
| 145 | FER | 0.41625525 |
| 146 | JAK3 | 0.40170747 |
| 147 | CDK9 | 0.40167386 |
| 148 | STK3 | 0.37591516 |
| 149 | RPS6KA2 | 0.37180209 |
| 150 | RET | 0.35155948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.29732807 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.56596298 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.17730651 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.76175922 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.64332410 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.54968593 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.44686523 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.42334895 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.36735021 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.17336143 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.09869709 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07947255 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03124709 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.00067617 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92930284 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92100485 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87531194 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.84380519 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83254857 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.80408008 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72938968 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67619432 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67336355 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62727474 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.61858593 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.59016812 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.58658271 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.58112962 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.56109542 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.49258316 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.44833383 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.42580671 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40907550 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39787395 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38262566 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35520988 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32697158 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.31867603 |
| 39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28555583 |
| 40 | * Lysosome_Homo sapiens_hsa04142 | 1.28225107 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24411786 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.23848735 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.20234865 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18621639 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18299543 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.16826446 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12946318 |
| 48 | Focal adhesion_Homo sapiens_hsa04510 | 1.11277178 |
| 49 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06902185 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.06266990 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.04241247 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03710404 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03149309 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.02349145 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01150049 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.98011096 |
| 57 | Adherens junction_Homo sapiens_hsa04520 | 0.97946895 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.97930106 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97329365 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96024241 |
| 61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95588636 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.93450441 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.93183928 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91629912 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91607313 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91093983 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90938145 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90179183 |
| 69 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89357272 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89061276 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87457317 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.85723378 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81330657 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79772316 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.79127563 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78106803 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.77442412 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.77392632 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76988404 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76445340 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76206489 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76122017 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74565352 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73528113 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73108506 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72857980 |
| 87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70615349 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70295324 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69364058 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68563736 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68405445 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67681772 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67559753 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67280514 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67003955 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66245502 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65071112 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64556047 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64545922 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63021450 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62705292 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.62545859 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62362066 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61366444 |
| 105 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61278807 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61159683 |
| 107 | Measles_Homo sapiens_hsa05162 | 0.60973646 |
| 108 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.60878850 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60305690 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58053039 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57772729 |
| 112 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56916421 |
| 113 | Malaria_Homo sapiens_hsa05144 | 0.56447798 |
| 114 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56180284 |
| 115 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56063217 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55522134 |
| 117 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55314923 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54534863 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54433612 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54263202 |
| 121 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54117537 |
| 122 | Prostate cancer_Homo sapiens_hsa05215 | 0.53785975 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53417987 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53195380 |
| 125 | Glioma_Homo sapiens_hsa05214 | 0.52768720 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50634755 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50376423 |
| 128 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.50276313 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50240681 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50006995 |
| 131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46015929 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.41884292 |
| 133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41846245 |
| 134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41061347 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38405500 |
| 136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37786465 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37748880 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.37739030 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35765981 |
| 140 | Pertussis_Homo sapiens_hsa05133 | 0.30896310 |
| 141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30169139 |
| 142 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27599753 |
| 143 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.27183071 |
| 144 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24997134 |
| 145 | Insulin resistance_Homo sapiens_hsa04931 | 0.24667066 |
| 146 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.22580137 |
| 147 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22562540 |
| 148 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.22023150 |
| 149 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20762767 |
| 150 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18435755 |
| 151 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17094884 |
| 152 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.16663779 |
| 153 | Amoebiasis_Homo sapiens_hsa05146 | 0.15901813 |
| 154 | Tuberculosis_Homo sapiens_hsa05152 | 0.15870836 |
| 155 | Hepatitis C_Homo sapiens_hsa05160 | 0.13690359 |
| 156 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12078219 |
| 157 | Leishmaniasis_Homo sapiens_hsa05140 | 0.11332611 |
| 158 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.10960771 |
| 159 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.10409183 |
| 160 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.07885033 |
| 161 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.07023589 |
| 162 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.06475694 |
| 163 | Endocytosis_Homo sapiens_hsa04144 | 0.06216752 |

